| P2093 | author name string | Luca Laurenti | |
| | Alessandra Ferrajoli | |
| | Paolo Strati | |
| | Francesco Autore | |
| P2860 | cites work | TP53 mutation profile in chronic lymphocytic leukemia: evidence for a disease specific profile from a comprehensive analysis of 268 mutations | Q85068912 |
| | Overall and cancer-specific survival of patients with breast, colon, kidney, and lung cancers with and without chronic lymphocytic leukemia: a SEER population-based study | Q85938416 |
| | Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines | Q24616084 |
| | CD38 Structure-Based Inhibitor Design Using the N1-Cyclic Inosine 5'-Diphosphate Ribose Template | Q27679016 |
| | Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation | Q27851655 |
| | Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia | Q27851685 |
| | The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial. | Q27851945 |
| | Genomic aberrations and survival in chronic lymphocytic leukemia | Q28141442 |
| | Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member | Q28268352 |
| | The cut-off levels of CD23 expression in the differential diagnosis of MCL and CLL | Q28274788 |
| | Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia | Q28394721 |
| | Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia | Q29614659 |
| | Clinical staging of chronic lymphocytic leukemia | Q33337604 |
| | The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphoma | Q33379107 |
| | Second cancers and Richter transformation are the leading causes of death in patients with trisomy 12 chronic lymphocytic leukemia | Q33421376 |
| | Adhesion molecules in B-chronic lymphoproliferative disorders | Q33630828 |
| | The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia | Q33655756 |
| | Trisomy 12 chronic lymphocytic leukemia cells exhibit upregulation of integrin signaling that is modulated by NOTCH1 mutations | Q33814458 |
| | Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia | Q33873337 |
| | CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. | Q33956997 |
| | Relevance of stereotyped B-cell receptors in the context of the molecular, cytogenetic and clinical features of chronic lymphocytic leukemia | Q34012864 |
| | Serum levels of soluble CD23, but not soluble CD25, predict disease progression in early stage B-cell chronic lymphocytic leukemia. | Q34066000 |
| | A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis | Q34282319 |
| | CD23: an overlooked regulator of allergic disease. | Q34662928 |
| | Chronic lymphocytic leukaemia CD20 expression is dependent on the genetic subtype: a study of quantitative flow cytometry and fluorescent in-situ hybridization in 510 patients | Q34759512 |
| | Insulin growth factor 1 receptor expression is associated with NOTCH1 mutation, trisomy 12 and aggressive clinical course in chronic lymphocytic leukaemia | Q35192691 |
| | High-level IGF1R expression is required for leukemia-initiating cell activity in T-ALL and is supported by Notch signaling | Q35208383 |
| | NOTCH1 mutations in CLL associated with trisomy 12. | Q35669190 |
| | CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential | Q35769292 |
| | NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL | Q35794466 |
| | Evolution and impact of subclonal mutations in chronic lymphocytic leukemia | Q36619124 |
| | Complex karyotype is a stronger predictor than del(17p) for an inferior outcome in relapsed or refractory chronic lymphocytic leukemia patients treated with ibrutinib-based regimens | Q36900364 |
| | Complex karyotype predicts for inferior outcomes following reduced-intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia | Q37036898 |
| | Comorbid conditions and survival in unselected, newly diagnosed patients with chronic lymphocytic leukemia | Q37059754 |
| | Percentage of smudge cells on routine blood smear predicts survival in chronic lymphocytic leukemia | Q37157694 |
| | Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma | Q37163867 |
| | Real-world clinical experience in the Connect® chronic lymphocytic leukaemia registry: a prospective cohort study of 1494 patients across 199 US centres. | Q37462177 |
| | Karyotype evolution on fluorescent in situ hybridization analysis is associated with short survival in patients with chronic lymphocytic leukemia and is related to CD49d expression | Q37554072 |
| | Modulation of immune cell signalling by the leukocyte common tyrosine phosphatase, CD45. | Q37622532 |
| | From pathogenesis to treatment of chronic lymphocytic leukaemia | Q37643423 |
| | Moving from prognostic to predictive factors in chronic lymphocytic leukaemia (CLL). | Q37771666 |
| | Antigens in chronic lymphocytic leukemia--implications for cell origin and leukemogenesis | Q37791678 |
| | A matter of debate in chronic lymphocytic leukemia: is the occurrence of autoimmune disorders an indicator of chronic lymphocytic leukemia therapy? | Q37890835 |
| | ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia | Q37980658 |
| | Microenvironmental interactions in chronic lymphocytic leukemia: hints for pathogenesis and identification of targets for rational therapy | Q38010501 |
| | Small lymphocytic lymphoma and chronic lymphocytic leukemia: are they the same disease? | Q38046044 |
| | CD49d associates with nodal presentation and subsequent development of lymphadenopathy in patients with chronic lymphocytic leukaemia | Q38848633 |
| | Mutations driving CLL and their evolution in progression and relapse | Q39714436 |
| | Does IL-2 receptor expression and secretion in chronic B-cell leukemia have a role in down-regulation of the immune system? | Q40804993 |
| | Clinical correlations of immunophenotypic variations and the presence of trisomy 12 in B-cell chronic lymphocytic leukemia | Q41486595 |
| | Cytogenetic and molecular cytogenetic analysis of B cell chronic lymphocytic leukemia: specific chromosome aberrations identify prognostic subgroups of patients and point to loci of candidate genes | Q41493765 |
| | Trisomy 12 CLLs progress through NOTCH1 mutations | Q42537461 |
| | CD40L stimulation enhances the ability of conventional metaphase cytogenetics to detect chromosome aberrations in B-cell chronic lymphocytic leukaemia cells | Q42811066 |
| | Prognostic impact and landscape of NOTCH1 mutations in chronic lymphocytic leukemia (CLL): a study on 852 patients | Q43555954 |
| | Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance | Q43722688 |
| | Very low levels of surface CD45 reflect CLL cell fragility, are inversely correlated with trisomy 12 and are associated with increased treatment-free survival | Q44052238 |
| | B-cell receptor configuration and mutational analysis of patients with chronic lymphocytic leukaemia and trisomy 12 reveal recurrent molecular abnormalities. | Q45940002 |
| | Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome | Q46585922 |
| | Percentage of smudge cells determined on routine blood smears is a novel prognostic factor in chronic lymphocytic leukemia | Q46872563 |
| | Insulin-like growth factor-1 receptor (IGF1R) as a novel target in chronic lymphocytic leukemia | Q47989294 |
| | Intratumoral genetic heterogeneity and number of cytogenetic aberrations provide additional prognostic significance in chronic lymphocytic leukemia. | Q48138435 |
| | FISHing in the dark: How the combination of FISH and conventional karyotyping improves the diagnostic yield in CpG-stimulated chronic lymphocytic leukemia. | Q50621489 |
| | The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation. | Q51609722 |
| | Prognostic markers and stratification of chronic lymphocytic leukemia. | Q51891213 |
| | Increased trisomy 12 frequency and a biased IgVH 3-21 gene usage characterize small lymphocytic lymphoma. | Q53062744 |
| | NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome. | Q53259951 |
| | Low CD23 expression correlates with high CD38 expression and the presence of trisomy 12 in CLL. | Q53450213 |
| | Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia. | Q53512382 |
| | Different distribution of NOTCH1 mutations in chronic lymphocytic leukemia with isolated trisomy 12 or associated with other chromosomal alterations. | Q54308638 |
| | Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations. | Q54580268 |
| | Chronic lymphocytic leukemia with t(14;19)(q32;q13) is characterized by atypical morphologic and immunophenotypic features and distinctive genetic features. | Q54595876 |
| | ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. | Q55036524 |
| | Stereotyped B-Cell Receptor Is an Independent Risk Factor of Chronic Lymphocytic Leukemia Transformation to Richter Syndrome | Q58001002 |
| | A high proportion of cells carrying trisomy 12 is associated with a worse outcome in patients with chronic lymphocytic leukemia | Q58041425 |
| | A different ontogenesis for chronic lymphocytic leukemia cases carrying stereotyped antigen receptors: molecular and computational evidence | Q58041611 |
| | Recurrent cytogenetic findings in subsets of patients with chronic lymphocytic leukemia expressing IgG-switched stereotyped immunoglobulins | Q58041617 |
| | Clinical, immunophenotypic, and molecular profiling of trisomy 12 in chronic lymphocytic leukemia and comparison with other karyotypic subgroups defined by cytogenetic analysis | Q58041632 |
| | Chronic lymphocytic leukemia | Q58042034 |
| | CD49d is overexpressed by trisomy 12 chronic lymphocytic leukemia cells: evidence for a methylation-dependent regulation mechanism | Q58319764 |
| | Incidence of chromosomal anomalies detected with FISH and their clinical correlations in B-chronic lymphocytic leukemia | Q58459410 |
| | The clinical and biological features of a series of immunophenotypic variant of B-CLL | Q60197171 |
| | Trisomy 19 is associated with trisomy 12 and mutatedIGHVgenes in B-chronic lymphocytic leukaemia | Q60345375 |
| | Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia | Q60358460 |
| | Expression of adhesion molecules in chronic B-cell lymphoproliferative disorders | Q61939597 |
| | Trisomy 12 in B-cell chronic lymphocytic leukemia: correlation with advanced disease, atypical morphology, high levels of sCD25, and with refractoriness to treatment | Q70820469 |
| | Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients | Q71005057 |
| | The two CD23 isoforms display differential regulation in chronic lymphocytic leukaemia | Q72585155 |
| | ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile | Q73023141 |
| | Clinico-prognostic implications of increased levels of soluble CD54 in the serum of B-cell chronic lymphocytic leukemia patients. Results of a multivariate survival analysis | Q73397775 |
| | Cell surface expression of CD25, CD54, and CD95 on B- and T-cells in chronic lymphocytic leukaemia in relation to trisomy 12, atypical morphology and clinical course | Q74311647 |
| | Molecular cytogenetic analysis of B-cell chronic lymphocytic leukemia | Q74628197 |
| | CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukemia | Q77139871 |
| | Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia | Q77637148 |
| | Immunostimulatory oligonucleotide-induced metaphase cytogenetics detect chromosomal aberrations in 80% of CLL patients: A study of 132 CLL cases with correlation to FISH, IgVH status, and CD38 expression | Q79903978 |
| | Analysis of CD23 antigen expression in B-chronic lymphocytic leukaemia and its correlation with clinical parameters | Q80467805 |
| | Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities | Q81040763 |
| | Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping | Q81099032 |
| | Chronic lymphocytic leukemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | Q84932151 |
| | NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL | Q84975869 |
| P433 | issue | 6 | |
| P921 | main subject | chronic lymphocytic leukemia | Q1088156 |
| P304 | page(s) | 931-938 | |
| P577 | publication date | 2018-05-10 | |
| P1433 | published in | Haematologica | Q5638209 |
| P1476 | title | Morphological, immunophenotypic, and genetic features of chronic lymphocytic leukemia with trisomy 12: a comprehensive review | |
| P478 | volume | 103 | |